TP53 and ovarian carcinoma: Interestingly, discordance between the p53 status of primary tumor cells and ascites-derived ovarian cancer cells has been reported in women where primary tumor cells are p53 wild-type, while ascites-derived cells have acquired a p53 mutation [67].